Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the …
Background—Secondary prevention therapies are indicated for patients with coronary artery
disease (CAD). However, patients with nonobstructive CAD may be less likely to receive …
disease (CAD). However, patients with nonobstructive CAD may be less likely to receive …
Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the …
TM Maddox, PM Ho, M Roe, TT Tsai… - … Quality and Outcomes, 2010 - europepmc.org
Background Secondary prevention therapies are indicated for patients with coronary artery
disease (CAD). However, patients with nonobstructive CAD may be less likely to receive …
disease (CAD). However, patients with nonobstructive CAD may be less likely to receive …
Utilization of Secondary Prevention Therapies in Patients With Nonobstructive Coronary Artery Disease Identified During Cardiac Catheterization
TM Maddox, PM Ho, M Roe, D Dai, TT Tsai… - … Quality and Outcomes, 2010 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background—</jats: title>< jats: p> Secondary prevention
therapies are indicated for patients with coronary artery disease (CAD). However, patients …
therapies are indicated for patients with coronary artery disease (CAD). However, patients …
Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: Insights from the national …
TM Maddox, PM Ho, M Roe, D Dai… - … Quality and Outcomes, 2010 - profiles.wustl.edu
Background: Secondary prevention therapies are indicated for patients with coronary artery
disease (CAD). However, patients with nonobstructive CAD may be less likely to receive …
disease (CAD). However, patients with nonobstructive CAD may be less likely to receive …
[引用][C] Utilization of Secondary Prevention Therapies in Patients With Nonobstructive Coronary Artery Disease Identified During Cardiac Catheterization: Insights From …
TM MADDOX, PM HO, M ROE, D DAI… - … and outcomes (Print …, 2010 - pascal-francis.inist.fr
Utilization of Secondary Prevention Therapies in Patients With Nonobstructive Coronary
Artery Disease Identified During Cardiac Catheterization: Insights From the National …
Artery Disease Identified During Cardiac Catheterization: Insights From the National …
Utilization of secondary prevention therapies in patients with nonobstructive coronary artery disease identified during cardiac catheterization: insights from the …
TM Maddox, PM Ho, M Roe, D Dai… - Circulation …, 2010 - pubmed.ncbi.nlm.nih.gov
Background Secondary prevention therapies are indicated for patients with coronary artery
disease (CAD). However, patients with nonobstructive CAD may be less likely to receive …
disease (CAD). However, patients with nonobstructive CAD may be less likely to receive …
[PDF][PDF] Utilization of Secondary Prevention Therapies in Patients With Nonobstructive Coronary Artery Disease Identified During Cardiac Catheterization
TM Maddox, PM Ho, M Roe, D Dai, TT Tsai… - 2010 - scholar.archive.org
Background—Secondary prevention therapies are indicated for patients with coronary artery
disease (CAD). However, patients with nonobstructive CAD may be less likely to receive …
disease (CAD). However, patients with nonobstructive CAD may be less likely to receive …